Drug Trial Radar · NCT01535469
Operational Research for Cryptococcal Antigen Screening
Last checked: Nov 19, 2026Latest source record: Jun 4, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,049
Actual
Start
Jul 1, 2012
Primary completion
Jun 2015
Study completion Jun 2015
Sponsor
- Lead sponsor
- University of MinnesotaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Infectious Diseases Institute, Uganda; Makerere University; Centers for Disease Control and Prevention
- First posted
- Feb 17, 2012
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 14 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This will be a stepped wedge randomized trial design to evaluate the implementation of cryptococcal antigen (CRAG) screening and preemptive anti-fungal therapy of HIV-infected persons entering antiretroviral therapy (ART) outpatient treatment in Uganda. Those who are ART eligible with a CD4≤100 cells/mcL will have a serum/plasma CRAG performed by lateral flow assay. Those who are CRAG-positive and asymptomatic will be treated with high dose fluconazole. After 6 months survival with retention-in-care will be compared between those who are CRAG+ and CRAG negative
Conditions
- Cryptococcal Meningitis
- Cryptococcus Neoformans
- Cryptococcosis
Interventions
FluconazoleDrug
Fluconazole 800mg orally daily for 2 weeks, then 400mg daily for 8 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Retention in careTime frame: 6-month
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Infectious Disease Institute, Makerere University
Kampala, Uganda
Kampala Capital Council Authority Clinics
Kampala, Uganda
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.